AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs

pallavi123- May 18, 2022 0

AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

pallavi123- March 18, 2022 0

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More

Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

Pallavi Madhiraju- February 20, 2022 0

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More

Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India

pallavi123- February 9, 2022 0

Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter's Nitric Oxide Nasal Spray under the brand name FabiSpray in ... Read More

Indian government approves use of Moderna’s Covid-19 Vaccine Moderna

pallavi123- June 29, 2021 0

US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years ... Read More

DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG

pallavi123- May 8, 2021 0

The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research and Development Organisation (DRDO) for the treatment ... Read More

CORAT begins COR-101 clinical trial in hospitalized Covid patients

pallavi123- April 26, 2021 0

CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101 for the treatment of hospitalized Covid-19 patients. ... Read More

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

pallavi123- March 27, 2021 0

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson ... Read More

Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205

pallavi123- March 16, 2021 0

Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical trial of CYTO-205 for the treatment of ... Read More

FDA grants emergency use authorization to Janssen COVID-19 vaccine

pharmanewsdaily- February 28, 2021 0

The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, Ad26.COV2.S, developed by Johnson & Johnson's ... Read More